Brandinium

Trademark search for:

UCBASSIST EPILEPSY SUPPORT, PERSONALIZED

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-08-29 — Application filed
  • 2016-09-01 — Application filed
  • 2016-09-01 — Application filed
  • 2016-09-02 — Teas voluntary amendment received
  • 2016-09-02 — Teas amendment entered before attorney assigned
  • 2016-09-22 — Assigned to examiner
  • 2016-09-27 — Examiners amendment -written
  • 2016-09-27 — Examiner's amendment entered
  • 2016-09-27 — Notification of examiners amendment e-mailed
  • 2016-09-27 — Examiners amendment e-mailed
  • 2016-10-13 — Final disposition recorded
  • 2016-10-13 — Final disposition recorded
  • 2016-10-13 — Final disposition recorded
  • 2016-11-22 — Office action issued
  • 2016-11-22 — Teas/email correspondence entered
  • 2016-11-22 — Correspondence received in law office
  • 2016-12-13 — Final disposition recorded
  • 2016-12-13 — Final disposition recorded
  • 2016-12-13 — Final disposition recorded
  • 2016-12-18 — Office action issued
  • 2016-12-18 — Correspondence received in law office
  • 2016-12-19 — Teas/email correspondence entered
  • 2016-12-28 — Office action issued
  • 2016-12-28 — Correspondence received in law office
  • 2016-12-28 — Teas/email correspondence entered
  • 2017-01-05 — Approved for pub - principal register
  • 2017-01-25 — Notification of notice of publication e-mailed
  • 2017-02-14 — Published for opposition
  • 2017-02-14 — Official gazette publication confirmation e-mailed
  • 2017-04-11 — Noa e-mailed - sou required from applicant
  • 2017-06-19 — Assigned to examiner
  • 2017-07-06 — Teas statement of use received
  • 2017-07-06 — Use amendment filed
  • 2017-08-02 — Case assigned to intent to use paralegal
  • 2017-08-03 — Statement of use processing complete
  • 2017-08-09 — Final disposition recorded
  • 2017-08-09 — Final disposition recorded
  • 2017-08-09 — Final disposition recorded
  • 2017-08-22 — Office action issued
  • 2017-09-05 — Assigned to lie
  • 2017-09-07 — Correspondence received in law office
  • 2017-09-07 — Teas/email correspondence entered
  • 2017-09-08 — Allowed principal register - sou accepted
  • 2017-09-09 — Notice of acceptance of statement of use e-mailed
  • 2017-10-17 — Registered-principal register
  • 2020-03-11 — Automatic update of assignment of ownership
  • 2022-05-12 — Attorney/dom.rep.revoked and/or appointed
  • 2022-05-12 — Teas withdrawal of attorney received-firm retains
  • 2022-05-12 — Teas change of owner address received
  • 2022-05-12 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-05-12 — Teas change of domestic representatives address
  • 2022-05-12 — Teas change of correspondence received
  • 2022-05-12 — Applicant/correspondence changes (non-responsive) entered
  • 2022-10-17 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2024-05-03 — Cancelled sec. 8 (6-yr)
  • 2024-05-03 — Final status recorded

Owner Information

UCB BIOPHARMA SRL
Brussels BE
UCB Biopharma SPRL
1070 Brussels BE
UCB Biopharma SPRL
1070 Brussels BE
UCB Biopharma SPRL
1070 Brussels BE

Correspondent

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.
1025 Connecticut Avenue NW, Suite 500
Washington, DC 20036
UNITED STATES

Filing Details

Filing Date:
2016-08-29
Status Date:
2024-05-03
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.